Resistance to anti-orthopoxviral drug tecovirimat (TPOXX(R)) during the 2022 mpox outbreak in the US https://www.medrxiv.org/content/10.1101/2023.05.16.23289856
CleverLibre Social is an inclusive social instance for open discussion, learning, and community. All cultures welcome. Hate speech and harassment strictly forbidden.